Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
Momentum Builds Across Programs with Key Data Milestones Expected in 2025Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in ...
George Herald16h
Treatment adherence – one of the most challenging issues in global health
Adherence – sticking to prescribed medications, lifestyle changes, and regular medical visits – is critical for managing ...